RNS Number:1833T
Protherics PLC
11 December 2003

Protherics PLC ("the Company")

Application has been made to the UK Listing Authority and to the London Stock
Exchange for admission to the Official List of 126,300 ordinary shares of 2p
each.

The shares rank pari passu in all respects with the existing ordinary shares in
issue. 116,300 shares have been allotted following exercise of a warrant that
was originally issued by Therapeutic Antibodies Inc. and was transferred to the
Company under the Merger Agreement dated 20 May 1999. 10,000 shares have been
allotted following exercise of a warrant that was issued on 1 November 2000 in
connection with loans originally made to Therapeutic Antibodies Inc. and renewed
since the date of merger.

It is expected that admission and dealings will become effective in the ordinary
shares on Monday 15 December 2003.

12 December 2003.


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

LISNKDKPKBDBBBD